Cognitive and Behavioural Disorder In Parkinson’s Disease
Updated: Aug 20, 2023
Talk Title: Cognitive and Behavioural Disorder In Parkinson’s Disease

Author: Aparna Gopi Senior Staff Nurse & Team lead at Tawam Hospital United Arab Emirates Email: apjis007@gmail.com Volume: Psychology and Human Behaviour 2023_CN40_AA01
International Live Conference on Psychology and Human Behaviour Date: August 19, 2023 Time: 8 PM Indian Standard Time Location: Online Conference Theme: Exploring the Depths: Unraveling the Intricacies of Human Behavior
Abstract Introduction: Parkinson’s disease is a progressive, neurodegenerative disorder of aging that affects both motor and cognitive function. While a number of non-motor manifestations arise, the typical clinical features involve a movement disorder consisting of bradykinesia, resting tremor and rigidity with postural instability occur at later stage. This article provides a review of the current understanding of Parkinson’s disease including the epidemiology, etiology , pathophysiology and treatment options of the disease. Recent Findings: Parkinson’s disease is now recognised to be a heterogeneous condition marked by both motor and non-motor symptoms. New medications with improved ease of administration have been approved for its treatment. Innovative surgical therapies for Parkinson’s disease may be used when motor symptoms persist despite optimal medical management. Conclusion: Parkinson disease is a chronic, progressive neurologic disorders that results from the loss of the neurotransmitter dopamine in a group of brain structures that control movement.The cardinal symptoms are resting tremors, rigidity akinesia and postural instability.The goal of management is to control the manifestations such as motor and non motor symptoms with the lowest possible dose of medication in order to avoid side effects.Medication selection and dosage depend on the manifestation, age of the client and presence of other medical condition.Nursing care should focus on the health assessment medication instruction and monitoring liaison with other members of the health care team and family members and family education. Keywords: Parkinson disease Neurotransmitter, heterogeneous condition Biography:
Aparna Gopi is an accomplished senior Registered Nurse with an impressive 13-year tenure in the field. Presently serving as a senior staff nurse within a prominent SEHA facility located in Abudhabi, she brings a wealth of expertise and dedication to her role.
Aparna's professional journey is characterized by a fervent dedication to nursing career advancement and an unwavering commitment to expanding her knowledge base. She has played an active role in diverse conferences and research initiatives, reflecting her passion for staying at the forefront of healthcare practices.
In pursuit of continued growth, Aparna is currently pursuing an MBA in healthcare management from Lincoln University in Malaysia. Her commitment to professional excellence is further demonstrated by her membership in the Emirates Nursing Association since 2023. Aparna Gopi's professional trajectory exemplifies her tireless pursuit of excellence in nursing and healthcare leadership.






